Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Observational
Started
2020-12-29
Last updated
2021-03-18
Condition(s) studied
Intracerebral Hemorrhage
Study summary
The investigators design a prospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective ,treatments and prognosis of Chinese hospitalised adult patients with intracerebral hemorrhage.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Hospitalized patients over 18 years old of primary intracerebral hemorrhage.
Exclusion Criteria:
1. patients of secondary intracerebral hemorrhage，such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arterio- venous malformations, central venous thrombosis, trauma-related, or tumor.
2. isolated intraventricular hemorrhage or subarachnoid hemorrhage pregnant patients；
3. surgical evacuation of hematoma；
4. unavailability to get complete blood cell samples and presenting contraindications or refusal to MRI
5. patients cannot be followed up for any reasons.
6. patients death in 24 hours
7. pregnant patients
Primary outcome measure(s)
proportion of patients with a 3-month modified Rankin Scale (mRS) score≤ 3 — 2-3years mRS 0-6, higher indicate worse outcome
Trial sites (1)
Facility
City
Region
Status
2nd Affiliated Hospital, School of Medicine at Zhejiang University
Hangzhou
Zhejiang
Recruiting
More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.